logo

PRVA

Privia Health·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 4
Bearish signal 3
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Gap Down
High Cash/net Profit Ratio
EPS Below Expectations
Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About PRVA

Privia Health Group, Inc.

A provider of technology-enabled healthcare services and physician practice management tools in the US

Healthcare Providers and Services
11/07/2007
04/29/2021
NASDAQ Stock Exchange
1,226
12-31
Common stock
950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203
--
Privia Health Group, Inc., was incorporated in Delaware on November 7, 2007. The company operates as a technology-driven, national doctor-empowered enterprise that partners with physician practices, health plans and health systems to achieve the quadruple goals of better healthcare outcomes, lower costs, improved patient experience and more provider engagement. Privia organizes physicians and non-physician clinicians into cost-effective, value-based networks that emphasize physician governance and leadership. Its proprietary Privia platform integrates a variety of applications to efficiently manage healthcare services, enhance the patient experience and improve practice economics. The platform is designed to accommodate different demographics and reimbursement models, including traditional Medicare and value-based care. Focusing on quality and provider autonomy, Privia aims to facilitate the transition from fee-for-service to value-based care, offering attractive revenue opportunities and aligning with the changing healthcare landscape.

Company Financials

EPS

PRVA has released its 2025 Q4 earnings. EPS was reported at 0.25, versus the expected 0.04, beating expectations. The chart below visualizes how PRVA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

PRVA has released its 2025 Q4 earnings report, with revenue of 541.17M, reflecting a YoY change of 17.42%, and net profit of 10.59M, showing a YoY change of 97.22%. The Sankey diagram below clearly presents PRVA's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data